New product: Jardiance™ (empagliflozin) 10/25 mg film-coated tablets -

New product: Jardiance™ (empagliflozin) 10/25 mg film-coated tablets
Information type: Drug prescribing
Source: Glenmark Pharmaceuticals Europe Ltd
Specialities: Diabetes
Summary
Empaglifozin is indicated as monotherapy (if metformin is not tolerated) and in combination with other glucose–lowering drugs in adults with type 2 diabetes mellitus if glycaemic control is inadequate despite other measures.
UKMi comment
An evidence summary on empagliflozin, produced by NICE (March 2014), is available via the link below.
Related links: NICE evidence summary